98%
921
2 minutes
20
Understanding how the public views harm reduction strategies may help inform researchers on how to reduce related stigma and barriers to help-seeking. The current study explored whether stigma towards those who use opioids was affected by gender and type of harm reduction strategy used. Undergraduate students ( = 328) were randomly assigned to read one of six vignettes varying by gender and the type of harm reduction strategy: no harm reduction, opioid agonist therapy (OAT), or safe consumption sites (SCSs). Results demonstrated that participants were less stigmatizing towards the character who engaged in OAT compared to the character with no harm reduction. There was also a pattern demonstrating that SCSs may be perceived more negatively than OAT, although these differences only met conventional significance, not adjusted/corrected alphas. There were no significant effects for gender. Qualitative results revealed that participants held misconceptions about harm reduction. Implications and future directions are discussed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773394 | PMC |
http://dx.doi.org/10.1007/s11469-022-00756-7 | DOI Listing |
Int J Drug Policy
September 2025
The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia. Electronic address:
Background: Drug-related deaths are a significant and growing public health concern. In Australia, meth/amphetamine is the most common stimulant drug involved in unintentional drug-related deaths. People who use meth/amphetamine often experience stigma and are negatively portrayed in the media.
View Article and Find Full Text PDFJ Sch Health
September 2025
Brigham and Women's Hospital, Boston, Massachusetts, USA.
Background: The opioid crisis continues to claim lives across the United States, which has led to increased attention toward harm reduction strategies as methods for addressing this public health issue. Specifically, naloxone, an opioid overdose reversal drug, became available over-the-counter in 2023, greatly improving its accessibility. However, despite this progress, general awareness about how to use naloxone remains limited, especially among youth who are being increasingly impacted by the opioid epidemic.
View Article and Find Full Text PDFLGBT Health
September 2025
Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Amid increasing political threats to sexual and gender minority (SGM) research, this perspective reflects on the evolution of SGM research from the margins of public health to a robust field and assesses the unique vulnerabilities facing SGM researchers across career stages. We discuss how the field can protect its infrastructure, sustain its workforce, and preserve its impact, drawing inspiration from the harm reduction movement and our individual and collective experiences. This is both a reflection and a call to action grounded in care, intergenerational knowledge and solidarity, and the refusal to be erased.
View Article and Find Full Text PDFSubst Use Addctn J
September 2025
Brain Boutique, Seoul, Korea.
Background: Misuse of anabolic-androgenic steroids (AAS), especially through "stacking" multiple substances, poses significant health risks. This study leverages data from the FDA's Adverse Event Reporting System (FAERS) to assess these risks and identify factors predicting severe outcomes.
Methods: We analyzed 286 FAERS reports of intentional AAS misuse.
Access Microbiol
September 2025
Department of Microbiology, Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, UK.
Optimization of diagnostic testing is essential for the sustainable delivery of laboratory services. To date, little consideration has been given to the potential benefits of diagnostic stewardship to laboratories looking to reduce their environmental footprint. Implementing a pre-analytical diagnostic stewardship intervention for the testing of superficial wound swabs would result in a measurable reduction in the environmental footprint of the microbiology laboratory.
View Article and Find Full Text PDF